Cargando…

Abaloparatide Exerts Bone Anabolic Effects with Less Stimulation of Bone Resorption-Related Factors: A Comparison with Teriparatide

Abaloparatide (ABL) is a novel synthetic peptide analog of parathyroid hormone-related protein. In previous reports, intermittent ABL administration showed robust bone mineral density (BMD) increase and reduced the incidence of fractures in patients with osteoporosis, while its calcemic effect was r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makino, Akito, Takagi, Hideko, Takahashi, Yoshimasa, Hase, Naoki, Sugiyama, Hiroyuki, Yamana, Kei, Kobayashi, Tsunefumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105163/ https://www.ncbi.nlm.nih.gov/pubmed/29725706 http://dx.doi.org/10.1007/s00223-018-0422-4

Ejemplares similares

Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice()
por: Arlt, Heike, et al.
Publicado: (2020)

Teriparatide and Abaloparatide Have a Similar Effect on Bone in Mice
por: Brent, Mikkel Bo, et al.
Publicado: (2021)

Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women With Osteoporosis
por: Dempster, David W, et al.
Publicado: (2021)

Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE
por: Eastell, R., et al.
Publicado: (2019)

Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database study
por: Cosman, F., et al.
Publicado: (2022)

OR03-2 Different Effects of Abaloparatide and h-PTH(1-34) on Osteoclastogenesis and Bone Resorption
por: Arlt, Heike, et al.
Publicado: (2019)

Is abaloparatide more efficacious on increasing bone mineral density than teriparatide for women with postmenopausal osteoporosis? An updated meta-analysis
por: Hong, Pan, et al.
Publicado: (2023)

Dasatinib as a Bone-Modifying Agent: Anabolic and Anti-Resorptive Effects
por: Garcia-Gomez, Antonio, et al.
Publicado: (2012)

Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption
por: Doyle, N., et al.
Publicado: (2017)

Gli1(+) progenitors mediate bone anabolic function of teriparatide via Hh and Igf signaling
por: Shi, Yu, et al.
Publicado: (2021)

Abaloparatide versus teriparatide: a head to head comparison of effects on fracture healing in mouse models
por: Bernhardsson, Magnus, et al.
Publicado: (2018)

Abaloparatide is an Effective Treatment Option for Postmenopausal Osteoporosis: Review of the Number Needed to Treat Compared with Teriparatide
por: Reginster, Jean-Yves, et al.
Publicado: (2018)

Comparative study in estrogen-depleted mice identifies skeletal and osteocyte transcriptomic responses to abaloparatide and teriparatide
por: Lv, Zhengtao, et al.
Publicado: (2023)

Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment
por: Iuliani, Michele, et al.
Publicado: (2015)

Differential effects of abaloparatide and teriparatide on hip cortical volumetric BMD by DXA-based 3D modeling
por: Winzenrieth, R., et al.
Publicado: (2021)

Cyclophilin A (CypA) Plays Dual Roles in Regulation of Bone Anabolism and Resorption
por: Guo, Mian, et al.
Publicado: (2016)

Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and β‐arrestin recruitment than teriparatide
por: Sahbani, Karim, et al.
Publicado: (2019)

Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone
por: Giveon, Sharon, et al.
Publicado: (2023)

SUN-385 Differential Effects of Abaloparatide and Teriparatide on Hip Cortical Volumetric BMD by DXA-Based 3d Modeling
por: Winzenrieth, Renaud, et al.
Publicado: (2020)

Comparable Initial Engagement of Intracellular Signaling Pathways by Parathyroid Hormone Receptor Ligands Teriparatide, Abaloparatide, and Long‐Acting PTH
por: Sato, Tadatoshi, et al.
Publicado: (2021)

Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia
por: Chandler, H., et al.
Publicado: (2019)

Phase 1b Evaluation of Abaloparatide Solid Microstructured Transdermal System (Abaloparatide-sMTS) in Postmenopausal Women with Low Bone Mineral Density
por: Miller, Paul D., et al.
Publicado: (2021)

Three-Times-Weekly Administration of Teriparatide Improves Vertebral and Peripheral Bone Density, Microarchitecture, and Mechanical Properties Without Accelerating Bone Resorption in Ovariectomized Rats
por: Takao-Kawabata, Ryoko, et al.
Publicado: (2015)

SUN-335 Abaloparatide Prevents Unloading-Induced Bone Loss in Adult Rats
por: Teguh, Dian A, et al.
Publicado: (2020)

Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States
por: Le, Quang A., et al.
Publicado: (2018)

Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a US linked claims and EMR database analysis
por: Imel, E.A., et al.
Publicado: (2020)

PSAT156 Abaloparatide Implementation and Follow-Up: Real-World Results of a Pharmacist-Run Anabolic Osteoporosis Clinic
por: Arceri, Veronica, et al.
Publicado: (2022)

Early Effects of Single and Low-Frequency Repeated Administration of Teriparatide, hPTH(1-34), on Bone Formation and Resorption in Ovariectomized Rats
por: Isogai, Yukihiro, et al.
Publicado: (2015)

Reduced bone formation and increased bone resorption drive bone loss in Eimeria infected broilers
por: Tompkins, Yuguo Hou, et al.
Publicado: (2023)

Teriparatide anabolic therapy as potential treatment of type II dens non-union fractures
por: Pola, Enrico, et al.
Publicado: (2017)

Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis
por: Watts, N.B., et al.
Publicado: (2019)

Abaloparatide Has the Same Catabolic Effects on Bones of Mice When Infused as PTH (1–34)
por: Le Henaff, Carole, et al.
Publicado: (2023)

Is RANKL inhibition both anti-resorptive and anabolic in rheumatoid arthritis?
por: Sims, Natalie A., et al.
Publicado: (2015)

Teriparatide Treatment for Hypercalcemia Associated With Adynamic Bone Disease
por: Peugh, Jennifer, et al.
Publicado: (2019)

Mechanisms of bone anabolism regulated by statins
por: Ruan, Feng, et al.
Publicado: (2012)

Anabolic Therapies in Osteoporosis and Bone Regeneration
por: Russow, Gabriele, et al.
Publicado: (2018)

Bone Flap Resorption Following Cranioplasty with Autologous Bone: Quantitative Measurement of Bone Flap Resorption and Predictive Factors
por: Park, Sang Pil, et al.
Publicado: (2017)

Withaferin A: a proteasomal inhibitor promotes healing after injury and exerts anabolic effect on osteoporotic bone
por: Khedgikar, V, et al.
Publicado: (2013)

Malignant melanoma and bone resorption
por: Lau, Y S, et al.
Publicado: (2006)

Roles of hyaluronan in bone resorption
por: Prince, Charles W
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_aea3votehsu6ng61fr90dmdm8s